cciresearch_03f3nm, Author at Centre for Cardiovascular Innovation

Hemodynamics After TAVR

Translational Cardiovascular Research Seminar SeriesHemodynamics After TAVR TWITTER Centre for Cardiovascular Innovation · @CCI_CIC Canadian Cardiovascular Society Receives $1.6 million to Study Myocarditis and/or Pericarditis after mRNA COVID-19 Vaccinationhttps://t.co/fDBddBvwvU View

cciresearch_03f3nm In Intervention/Structural ACS Cardiac Surgery

CTCR-MVS Trial

Journal Club - December 2, 2021CTCR-MVS Trial Dr. Nav Malhi presented the CTCR-MVS Trial, which is a randomized, surgical trial comparing mitral valve surgery with or without tricuspid annuloplasty (TA) among patients who were undergoing mitral-valve

cciresearch_03f3nm In Awards, News

2021 UBC Faculty of Medicine Awards

Congratulations to the UBC Department of Medicine recipients of the 2021 UBC Faculty of Medicine Awards Each year, the UBC Faculty of Medicine recognizes outstanding faculty and staff who are

cciresearch_03f3nm In Intervention/Structural ACS Cardiac Surgery

IAMI Trial

Journal Club - October 28, 2021IAMI Trial Dr. Kurt Hoskin presented the IAMI Trial, which is an investigator-initiated, randomized, double-blind trial to compare inactivated influenza vaccine with saline placebo administered

cciresearch_03f3nm In Intervention/Structural ACS Cardiac Surgery

TAVR Explant: An Emerging Necessity in the Lifetime Management of Aortic Valve Disease

Journal Club - October 20, 2021TAVR Explant: An Emerging Necessity in the Lifetime Management of Aortic Valve Disease Dr. Gilbert Tang, Surgical Director of the Structural Heart Program at the

cciresearch_03f3nm In Intervention/Structural ACS Cardiac Surgery

TOMAHAWK Trial

Journal Club - October 14, 2021TOMAHAWK Trial Dr. Curtis Williams presented the TOMAHAWK Trial, which is a multicenter, randomized clinical trial comparing immediate coronary angiography to initial intensive care assessment with delayed or selective angiography among

cciresearch_03f3nm In Heart Function Transplant Cardiology-Oncology Pulmonary Vascular PACCH

EMPEROR-Preserved Trial

Journal Club - September 2, 2021EMPEROR-Preserved Trial Dr. Charmaine Lam will presented the EMPEROR-Preserved Trial, which is a double-blind, randomized control trial comparing the use of empagliflozin (10mg) to placebo

cciresearch_03f3nm In News

Native Aortic Valve Disease Progression and Bioprosthetic Valve Degeneration in Patients with Transcatheter Aortic Valve Implantation

CCI-CIC investigators participated in a Late Breaking study presented at ESC Congress last weekend Abstract Background: There remain major uncertainties regarding disease activity within the retained native aortic valve as well

cciresearch_03f3nm In Intervention/Structural ACS Cardiac Surgery

TTM2 Trial

Journal Club - August 12, 2021TTM2 Trial Dr. Ian Pitcher presented the TTM2 Trial, which is an open-label trial with blinded assessment of outcomes comparing targeted hypothermia at 33°C, followed

cciresearch_03f3nm In Heart Function Transplant Cardiology-Oncology Pulmonary Vascular PACCH

REHAB-HF

Journal Club - June 17, 2021REHAB-HF Dr. Andy Dhaliwal presented the REHAB-HF Trial, which is a multicentre, randomized, controlled trial to evaluate the benefit of a tailored progressive rehabilitation intervention